Black Rock Inc. Enochian Biosciences Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Black Rock Inc. holds 3,656,954 shares of ENOB stock, worth $16.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,656,954
Previous 314,314
1063.47%
Holding current value
$16.8 Million
Previous $1.45 Million
1064.08%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ENOB
# of Institutions
51Shares Held
14.7MCall Options Held
24KPut Options Held
19.1K-
Vanguard Group Inc Valley Forge, PA5.72MShares$26.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.57MShares$7.23 Million0.0% of portfolio
-
State Street Corp Boston, MA1.32MShares$6.09 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL595KShares$2.74 Million0.0% of portfolio
-
Morgan Stanley New York, NY357KShares$1.64 Million0.0% of portfolio
About Enochian Biosciences Inc
- Ticker ENOB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,950,000
- Market Cap $244M
- Description
- Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...